The Distribution and Mechanism of Action of Ghrelin in the CNS Demonstrates a Novel Hypothalamic Circuit Regulating Energy Homeostasis  by Cowley, Michael A et al.
Neuron, Vol. 37, 649–661, February 20, 2003, Copyright 2003 by Cell Press
The Distribution and Mechanism of Action
of Ghrelin in the CNS Demonstrates a Novel
Hypothalamic Circuit Regulating Energy Homeostasis
Summary
The gastrointestinal peptide hormone ghrelin stimu-
lates appetite in rodents and humans via hypothalamic
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an opposite direction (Tung et al., 2001; Horvath et al.,
2001; Tschop et al., 2002; Kamegai et al., 2001). The
coactivation of NPY- and AGRP-dependent pathways
(Kamegai et al., 2000; Shintani et al., 2001; Nakazato et
al., 2001; Wren et al., 2001b; Tschop et al., 2002) by
ghrelin may play an endogenous role in appetite stimula-
tion and energy supply, since administration of ghrelin
antiserum or ghrelin receptor antagonists prevents a
ghrelin-induced generation of a positive energy balance
(Nakazato et al., 2001). Because circulating ghrelin is
predominantly derived from the stomach and intestine
and may bind at hypothalamic target neurons, its puta-
tive transfer across the blood-brain barrier becomes
an important factor. Surprisingly, it was observed in a
mouse model that acylated ghrelin is readily transported
across the blood-brain barrier in the brain-to-blood di-
rection, but the quantity of its transport in the blood-to-
brain direction appears to be negligible (Banks et al.,
2002). A very recent finding revealing that vagotomy
prevents peripheral ghrelin’s effect on the hypothalamus
(Date et al., 2002) also suggest that ghrelin’s direct effect
on the brain (Tschop et al., 2000; Nakazato et al., 2001)
may be of intrinsic origin. We therefore investigated if,
and by which mechanisms, an additional central source
of ghrelin could be responsible for balancing leptin’s
actions in the hypothalamic regulation of energy
balance.
We analyzed the expression patterns of ghrelin in the
hypothalamus, the specific neuronal sites of ghrelin
binding, and its electrophysiological effects on circuits
previously shown to be leptin responsive. We investi-
gated the complex actions upon neuropeptide circuits
that regulate feeding and metabolism to establish an
integrated concept of the role of central ghrelin in the
regulation of energy homeostasis.
Results
Expression of Ghrelin in the Brain
Early studies of ghrelin mRNA distribution demonstrated
expression in the brain (Kojima et al., 1999), and our RT-
PCR analysis of rat stomach and hypothalamus RNA
showed a 320 bp product (Figure 1A, top). This product
was then sequenced and found to correspond perfectly
(data not shown) with the published ghrelin sequence
(Kojima et al., 1999). In further support of ghrelin produc-
tion in the brain, no ghrelin mRNA was detected in the
hypothalamus of ghrelin knockout mice, while their wild-
type littermates showed similar expression pattern as
described for the rat (data not shown).
Next, we analyzed the existence of ghrelin protein in
the hypothalamus using three antisera, which had been
of RT, 10 l of PCR product loaded onto the gel) compared to the
stomach (50 ng of RT, 5 l of PCR product loaded onto the gel).
Western blot analyses show (bottom) that the antibody labels a
band around 13 kDa that corresponds to the size of pro-ghrelin.
Figure 1. Ghrelin mRNA and Peptide Expression in the Hypo- Note that 100 g of hypothalamic protein (Hyp) was loaded while
thalamus for the stomach 30 g was loaded. The ghrelin level in the stomach
(A) Ghrelin expression in the rat stomach and hypothalamus. PCR is several fold higher than in the total hypothalamus.
products (top) were separated on a 1.5% agarose gel stained with (B) Schematic illustration of ghrelin-immunoreactive cell bodies (red)
ethidium bromide. It should be noted that approximately four times and projections (red dots) within the hypothalamus and adjacent
the material was loaded onto the gel for the hypothalamus (100 ng areas at different distances from Bregma.
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Figure 2. Ghrelin in Hypothalamic Neurons and Their Efferents
(A–C) Distribution of ghrelin-immunoreactive (IR) perikarya in an area between the arc, PVH, DMH, and VMH. Scale bar in (A) represents 300
m (for A–D). Each image shows the immunoreactivity pattern with a different primary antiserum. Top and bottom insets in (C) are high-
magnification images of a ghrelin-immunolabeled cell body and axonal varicosity, respectively. Scale bar in top inset represents 10 m for
both insets.
(D) Stomach and hypothalamus from wild-type and ghrelin knockout animals immunolabeled for ghrelin. Top left and right images show
hypothalamic sections (corresponding to those depicted in A–C) from a wild-type animal and a ghrelin knockout mouse, respectively. Bottom
left and right images show stomach crossections immunolabeled for ghrelin from a wild-type mouse and a ghrelin knockout littermate,
respectively. Note that no specific staining could be found in either the hypothalamus (top right) or the stomach (bottom right) in ghrelin
knockout animals.
(E–G) Ghrelin immunopositive axon terminals (arrowheads) in close proximity to an NPY-immunoreactive (E) and POMC-immunoreactive (F)
perikarya in the arcuate nucleus and a CRF-positive cell body in the PVH (G). Scale bar in (E) represents 10 m for (E)–(G).
(H) NPY-IR axon terminals (red fluorescence) in direct apposition to ghrelin-IR boutons (green fluorescence) in the PVH.
(I) Electron micrograph showing ghrelin immunoreactivity in dense-cored vesicles of an axon terminal. Scale bar represents 1 m for (I)–(L).
(J) Electron micrograph showing a symmetrical synaptic membrane specialization (black arrows) between a ghrelin-immunolabeled axon
terminal (25 nm immunogold in dense-cored vesicles) and an unlabeled dendrite.
(K) Electron microscopy revealed direct appositions between ghrelin (immuno peroxidase in dense-cored vesicles) and NPY-producing
presynaptic terminals (25 nm immunogold in dense-cored vesicles).
(L) Direct apposition between ghrelin (25 nm immunogold particles) and GABA (10 nm immunogold particles; arrowheads) axon terminals
presynaptic to an immuno-labeled TRH perikaryon in the PVH.
independently generated against ghrelin. In Western ghrelin in the hypothalamus and stomach (Figure 2D)
using these antisera. In colchicine-treated animals, theblots, these antisera labeled a band that corresponds
to the nonsecreted ghrelin prohormone (13 kDa) (Figure intensity and number of labeled cells in this area was
enhanced, which is a characteristic feature of several1A, bottom), confirming that ghrelin is produced in the
hypothalamus. hypothalamic peptidergic systems. Ghrelin-immunore-
active neurons had a mostly bipolar shape and fre-Ghrelin-immunoreactive cell bodies were detected in
the hypothalamus of rats and mice and were distributed quently exhibited rectangular appearance (Figure 2C,
top inset).in a continuum filling the internuclear space between the
lateral hypothalamus (LH), arcuate (ARC), ventromedial Ghrelin was robustly expressed in axons (Figures 1B,
2C [bottom inset], and 2E–2L; Table 1) and was associ-(VMH), dorsomedial (DMH), and paraventricular hypo-
thalamic nuclei (PVH) and the ependymal layer of the ated with dense-cored vesicles in presynaptic terminals
(Figures 2I–2L). The synaptic membrane specializationsthird ventricle (Figures 1B and 2A–2C; Table 1). Ghrelin
knockout animals expressed no immunolabeling for were not always clear, as is the case frequently in the
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Table 1. Ghrelin Immunoreactivity in the Forebrain and Diencephalon
Cell Bodies Processes
Thelencephalon
Cortex  
Hippocampus  
Caudate-putamen  
Nucleus accumbens  
Central nucleus of amygdala  
Cortical nucleus of amygdala  
Basolateral nucleus of amygdala  
Medial nucelus of amygdala  
Bed nucleus of stria terminalis  
Medial septum  
Lateral septum  
Diencephalon
Organum vasculosum laminae terminalis  
Medial preoptic area
Lateral preoptic area  
Anterior hypothalamus
Periventricular area  
Supraoptic nucleus
Suprachiasmatic nucleus  
Paraventricular nucleus (magnocellular)  
Paraventricular nucleus (parvicellular)  () 
Lateral hypothalamus  () 
Perifornical region  
Retrochiasmatic area  () 
Arcuate nucleus  () 
Dorsomedial hypothalamic nucleus  () 
Ventromedial hypothalamic nucleus  () 
Zona incerta  
Intergeniculate leaflet of the lateral geniculate body  
Thalamic paraventricular nucleus  
Lateral habenula  
Ghrelin cell bodies were found in the periventricular area connected with a continuum between the paraventricular, dorsomedial, arcuate,
and ventromedial nuclei and lateral hypothalamus. Plus sign indicates nuclei associated with cell bodies producing ghrelin.
mediobasal hypothalamus; however, when detectable, tors has not been explored. To gain further insights into
neuronal sites of ghrelin action, we analyzed bindingthey appeared to be Gray type II, symmetrical synaptic
contacts (Figure 2J). of biotin-labeled ghrelin to coronal slices of the brain.
Biotinylated ghrelin bound to hypothalamic regions, in-Ghrelin-containing axon terminals innervated several
hypothalamic nuclei, including the ARC, DMH, LH, and cluding the ARC (Figures 3A and 3B), LH (Figure 3C),
and PVH (Figure 3E); these regions all express thePVH. While not the main focus of this manuscript, ghrelin
projections were also detected outside the hypothala- GHS-R (Willesen et al., 1999; Guan et al., 1997). Ghrelin
binding was also observed in the cortex (Figure 3D).mus, including the bed nucleus of stria terminalis, me-
dial, central, and cortical amygdale, the thalamic para- Biotinylated ghrelin binding was specific, since it was
prevented by pretreatment with an excess of unlabeledventricular nucleus, and lateral habenula (Table 1).
Detailed description of ghrelin projections throughout ghrelin (Figures 3H–3J). Ghrelin binding was predomi-
nantly localized to presynaptic boutons (Figures 3B–3E).the brain will be the focus of another manuscript.
Regarding hypothalamic systems implicated in me- In the hypothalamus, axon terminals that bound ghrelin
frequently also contained NPY (Figures 3F and 3G). Intabolism regulation, ghrelin boutons established synap-
tic contacts on cell bodies and dendrites of NPY/AGRP addition, anatomical proximity of ghrelin and NPY fibers
was detected throughout the hypothalamus (Figures 2H(Figure 2E) and POMC (Figure 2F) neurons in the arcuate
nucleus. Light and electron microscopic analysis with and 2K).
single and multiple labels also revealed that ghrelin bou-
tons were in direct apposition to NPY and GABA axon Electrophysiological Effects of Ghrelin
To gain further insights into the mechanism of ghrelinterminals in the ARC and PVH (Figures 2H, 2K, and 2L).
In the PVH, some of the ghrelin axons innervated CRH actions, we assessed the electrophysiological effects
of ghrelin in vitro using hypothalamic slices from micecells (Figure 2G).
and rats, looking at NPY neurons and previously defined
sites of leptin, AGRP, and NPY action in the ARC (AhimaGhrelin Binding within the Brain
While data are available on the localization of GHS-R et al., 2000; Cowley et al., 2001) and in the PVH (Powis
et al., 1998). Some hypothalamic slices were preparedmRNA in the hypothalamus (Willesen et al., 1999; Guan
et al., 1997), the subcellular localization of these recep- from transgenic mice expressing sapphire green fluo-
Ghrelin in the CNS
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Figure 3. Ghrelin Binding throughout the Hypothalamus
(A) Biotinylated ghrelin binds to hypothalamic areas, including the ARC, DMH, and me. Scale bar represents 300 m for (A), (H), and (J).
(B–E) Ghrelin binding is associated with axon terminals in the ARC (B), LH (C), cortex (D), and PVH (E). Arrowheads in (B), (C), and (E) point
to labeled boutons. Scale bar in (C) represents 10 m for (B), (C), and (E)–(G). Scale bar in (D) represents 10 m for (D), (I), and (K).
(F and G) Axon terminals that bound labeled ghrelin (F, red fluorescence; green arrowheads point to some of the labeled presynaptic terminals)
were frequently immunopositive for NPY (G, green fluorescence; red arrowheads point to those NPY-immunolabeled boutons that are indicated
with green arrows in F).
(H–J) Biotinylated ghrelin binding (H and I) is abolished when coincubated with unlabaled ghrelin (J and K). (I) and (K) are high-magnification
views of (H) and (J), respectively.
rescent protein (SFP) under the control of NPY regula- fluorescent protein under the control of proopiomelano-
cortin (POMC) genomic regulatory elements (POMC-tory elements (NPY-SFP mice), and these mice eutopi-
cally express SFP in NPY neurons (see Figure 4A); a GFP mice; Figure 4A; Cowley et al., 2001). In patch-
clamp recordings from visually identified, arcuate POMCdetailed description of these animals is the subject of
another submission. neurons, ghrelin (50–100 nM) treatment was observed
to increase the frequency of spontaneous GABAergicGhrelin (50 nM) increased the activity of NPY neurons
3.7-fold within 4 min (Figure 4B; n  9); this increased inhibitory postsynaptic currents (IPSCs) onto POMC
neurons (by up to 300%, mean  149%  14%; n  18;activity was reversible with washout. This finding
showed that ghrelin was likely increasing the release of p  0.006; Figure 4C). These IPSCs were previously
shown to be due to GABA secretion from NPY neuronsNPY and AGRP at targets of arcuate NPY/AGRP neu-
rons. Coincident with its effect on the spontaneous ac- (Cowley et al., 2001) and correlate temporally with the
increase in the activity of NPY neurons shown in Figuretivity of NPY neurons, ghrelin also depolarized identified
NPY neurons (11.8 2.1 mV; n 3). This dose of ghrelin 4B. This increased quantal secretion of GABA onto
POMC neurons was accompanied by a 65%  19%was chosen because it is close to the EC50 for ghrelin at
the GHS-R (32 nM) (Bednarek et al., 2000). Unfortunately, decrease in the spontaneous activity of POMC neurons
(Figure 4D; n  6) and a small, but significant, hyperpo-we were not able to identify the specific ion conductance
that was modified by ghrelin, probably because of poor larization (Figure 4E; range 0.4 to 13 mV, mean 1.47 
0.7 mV; p  0.03, n  34), consequently decreasing thevoltage clamp in the slice preparation.
We examined the effect of ghrelin on POMC neurons frequency of action potentials in these neurons.
Blockade of GABAA receptors (picrotoxin 100 M) didusing hypothalamic slices from mice expressing green
Neuron
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Figure 4. Ghrelin Increases the Spontaneous Activity of NPY Neurons and Inhibits POMC Neurons by Increasing the Inhibitory Tone onto
Them
(A) Arcuate NPY and POMC neurons were selectively immunoreactive for GFP taken from two lines of transgenic mice that were analyzed in
electrophysiological studies.
(B) Ghrelin (50 nM) increases the spontaneous activity of arcuate NPY neurons (n  9).
(C) Ghrelin increases the frequency of spontaneous synaptic GABA release onto POMC neurons; figure is representative of 18 experiments.
(D) Ghrelin (50 or 100 nM) decreases the spontaneous activity of arcuate POMC neurons (n  6).
(E) Ghrelin (100 nM) decreases the spontaneous activity of POMC neurons and causes a mild hyperpolarization; figure is representative of 34
experiments.
(F) When NPY and GABA effects upon POMC neurons are blocked (with BIBP 3026 and picrotoxin), ghrelin depolarizes POMC neurons. Figure
is representative of four experiments.
not alter the ghrelin-induced hyperpolarization of the al., 1998; Horvath et al., 1997), possibly because AGRP
antagonizes the tonic inhibition of POMC neurons medi-POMC neurons (1.9  1.4 mV hyperpolarization, n  9,
not significant), suggesting that ghrelin was stimulating ated by the auto-inhibitory melanocortin-3 receptor
(MC3-R) (Cowley et al., 2001; Fong et al., 1997). In sup-the release of another factor, most likely NPY (Cowley
et al., 2001), that, in turn, would hyperpolarize the POMC port of this premise, preliminary data suggests that
AGRP (100 nM) treatment depolarizes POMC neuronsneuron. Indeed, blockade of NPY Y1-receptors (the NPY
receptor subtype expressed on POMC neurons) (Fuxe (8  0.8 mV, n  3), although this data did not reach
significance. In further support of the data that ghrelinet al., 1997) with a specific antagonist (BIBP 3226, 500
nM) and blockade of GABAAR together reversed ghrel- activates NPY/AGRP neurons, we found that ghrelin
strongly depolarized 8 of 11 non-POMC neurons (14.1in’s hyperpolarizing effect on POMC neurons and un-
masked a paradoxical, ghrelin-induced depolarization 3.9 mV: n  8, p 0.03) in the ARC of POMC-GFP mice,
activating some that were previously silent.of POMC neurons (Figure 4F). This ghrelin-induced de-
polarization may be due to ghrelin stimulating secretion We also analyzed the effects of ghrelin on neuronal
activity of the PVH, an area targeted by efferents of ARCof AGRP from the NPY/AGRP/GABA terminal (Hahn et
Ghrelin in the CNS
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Figure 5. Electrophysiological Actions of Ghrelin in mpPVH Neurons
(A) Effect of 30 nM ghrelin on the IPSC of a mpPVH neuron. Shown superimposed are two traces, one taken in control and one in the presence
of ghrelin. Inset: net (ghrelin  control) steady-state membrane current response to a voltage ramp (110 mV to 40 mV).
(B) IPSC response to ghrelin of neuron in (A) after pretreatment with Y1 and Y5 receptor antagonists.
(C) The effect of ghrelin is attenuated by NPY antagonists in mpPVH neurons.
(D) Effect of ghrelin on PVH neuron IPSC.
(E) Effect of NPY on IPSC of neuron in (D).
(F) Time course of ghrelin (closed circle; 30–100 nM) and NPY (closed triangle; 100–300 nM) actions on the IPSC of PVH neurons.
NPY and POMC neurons. In conventional and perforated sis that ghrelin action in the PVH results from NPY re-
lease. In the ghrelin-responsive neuron of Figure 5A,patch whole-cell recordings the GABAergic inputs to
73% of medial PVH neurons was inhibited (28% 1.5%) preapplication of a cocktail of NPY Y1 and Y5 antagonists
(BIBO 3304, 500 nM; Novartis 2, 500 nM, respectively)by ghrelin (Figure 5A), while 27% of cells showed no
effect of ghrelin. We have previously shown that NPY substantially reduced or blocked the effect of ghrelin
(Figure 5B). In 5 of 11 ghrelin-sensitive neurons tested,exerts an identical effect on these neurons, which results
from a presynaptic reduction of GABA release rather this antagonist cocktail reduced the ghrelin effect by
59%  12% (n  5, p  0.005; Figure 5C). Furthermore,than a change in the response to GABA (Cowley et al.,
1999). This response to ghrelin was not accompanied in 2 of 4 ghrelin-responsive cells insensitive to the Y1
and Y5 antagonist cocktail, additional application of theby a significant change in the membrane current-voltage
relationship, expressed as net current (Figure 5A, inset), Y2 receptor antagonist, BIIE0246 (100 nM), reduced or
blocked the ghrelin effect (not illustrated).also consistent with a presynaptic action by ghrelin.
Because ghrelin binding was colocalized at NPY-immu- Application of NPY always inhibited the IPSC in
ghrelin-sensitive neurons in PVH. Figure 5D shows thenoreactive terminals in the PVH, we tested the hypothe-
Neuron
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Discussion
Anatomy of Ghrelin Neurons
Ghrelin immunoreactive neurons were observed in a
continuum filling the internuclear space between the
paraventricular, arcuate, ventromedial, and dorsomedial
hypothalamic nuclei, the perifornical region, and the ep-
endymal layer of the third ventricle. The observed distri-
bution pattern of ghrelin cells is different to previously
published reports (Kojima et al., 1999) and highlights a
novel cell group. Their unique distribution did not over-
lap with any of the known hypothalamic cell populations
implicated in energy homeostasis, including those pro-
ducing NPY, AGRP, POMC, melanin concentrating hor-
mone, orexin, dopamine, and somatostatin (Chronwall
et al., 1985; Haskell-Luevano et al., 1999; Oliver et al.,
1977; Zamir et al., 1986; Sakurai et al., 1998; de Lecea
et al., 1998; Brownstein et al., 1975). The discovery of a
novel hypothalamic cell distribution argues for a unique
central role for ghrelin, in addition to its role as a periph-
eral hormone secreted by gastric endocrine glands (Ko-
jima et al., 1999).
The subcellular appearance of ghrelin by electron mi-
croscopy established that hypothalamic ghrelin may be
secreted, and ghrelin axon terminals were found to in-
nervate other hypothalamic peptidergic systems that
are involved in metabolism regulation, including those
producing AGRP and POMC in the arcuate nucleus and
CRH and TRH in the paraventricular nucleus. These find-
ings provide an anatomical basis for potential pre- and
postsynaptic interactions between ghrelin and NPY/
AGRP, POMC, and CRH circuits, which are critical cen-
tral regulators of energy homeostasis (Kalra et al., 1999).
The existence of ghrelin in axon terminals of hypothala-
mic regions that are important to metabolic regulation,
Figure 6. Triple-Label Immunocytochemistry of PVH Neurons after including the ARC and PVH, suggests that ghrelin pro-
Perforated-Patch Recording and Electroporation duced in the hypothalamus may modulate the activity of
(A) A CRH-positive (green fluorescence image) but TRH immunoneg- hypothalamic neurons to regulate energy homeostasis.
ative (red fluorescence image) neuron that was filled with biocytin The apparent anatomical proximity of ghrelin and NPY(blue fluorescence image). Lower right is merged images of the CRH,
fibers further supports the concept that hypothalamicbiocytin, and TRH labelings. Scale bar represents 10 m.
ghrelin is part of a central regulatory loop modulating(B) Electrophysiological recordings revealed an inhibitory effect of
100 nM ghrelin on IPSC of CRH neurons. orexigenic drive.
Interestingly, while ghrelin immunolabeling was
mainly present in the hypothalamus, ghrelin binding was
also present in extrahypothalamic sites, including theIPSC response to ghrelin in a PVH neuron; Figure 5E
cerebral cortex, raising the possibility that either periph-shows the response to NPY in the same neuron. The
erally circulating ghrelin can cross the blood-brain bar-magnitude and time course of the response to ghrelin
rier to reach these cortical sites, or that additional en-(30–100 nM; n  16) and to NPY (100–300 nM) applied
dogenous ligands exist for the GHS-R and/or that ghrelinto ghrelin-sensitive neurons (n  9) is shown in Figure
may have affinity to receptors other than the currently5F. Thus, NPY and ghrelin act on the inputs to the same
known GHS-Rs.PVH neurons in the same manner.
To identify the neuropeptide phenotype of neurons
that showed a ghrelin-sensitive IPSC, we filled PVH neu- Physiology of Ghrelin’s Effect
The extensive apposition between terminals of hypo-rons (n 20) with biocytin at the conclusion of a perfora-
ted patch electrophysiological recording and tested for thalamic neurons and ghrelin-expressing boutons sug-
gested a presynaptic mode of action of ghrelin in thecolocalization of the intracellular marker with CRH and
thyrotropin-releasing hormone (TRH) immunoreactivity. hypothalamus. Both the binding data and the expression
of ghrelin in axons adjacent to presynaptic nerve termi-Eight of twenty mpPVH neurons we analyzed expressed
CRH, and seven of these neurons showed a decreased nals suggested that ghrelin may exert modulatory ef-
fects on neurotransmission. The dependence of ghrelinIPSC in response to ghrelin (Figures 6A and 6B). Two
of twenty mpPVH neurons we analyzed expressed TRH, on NPY and AGRP in affecting food intake (Nakazato
et al., 2001; Tschop et al., 2002; Kamegai et al., 2001;and neither of these neurons appeared to be sensitive
to ghrelin (30–100 nM) in relation to IPSC. Shintani et al., 2001) and data showing colocalization
Ghrelin in the CNS
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Figure 7. Schematic Drawing Summarizing
the Interaction between Ghrelin and Other
Hypothalamic Circuits
Model of proposed sites of ghrelin activity in
the hypothalamus. The axons of hypothala-
mic ghrelin neurons abut NPY axons presyn-
aptically in the arcuate nucleus and in the
PVH. Ghrelin binds to, and acts via, GHS-R’s
to increase the activity of the terminals of NPY
axons. Ghrelin increases the rate of secretion
of GABA and may increase the secretion of
NPY and AGRP: this altered GABA and neuro-
peptide secretion modulates the activity of
postsynaptic POMC and CRH neurons.
Ghrelin from plasma may also bind to and
activate GHS-R’s in the arcuate nucleus, but
it is not likely to access GHS-R’s in the PVH.
of NPY and c-fos following peripheral ghrelin administra- and hypothalamo-pituitary-thyroid axes (Arvat et al.,
2001; Wren et al., 2000). Half of the mpPVH neurons wetion (Wang et al., 2002) suggested that ghrelin was acting
on NPY neurons and thus on many of the same circuits analyzed did not have detectable colocalization with
either CRH or TRH, and nine of these neurons showedas does leptin (Spanswick et al., 1997). Indeed, we ob-
served that ghrelin induced depolarization of arcuate a ghrelin-induced inhibition of the IPSC amplitude. It
needs to be considered, however, that CRH or TRHnucleus NPY neurons. To examine the consequences
of this increased NPY neuronal activity, we looked at immunolabeling in parvicellular perikarya is enhanced
by colchicine pretreatment, which was not done duethe effects of ghrelin on POMC neurons in the ARC. Our
electrophysiological observations showed that ghrelin to its interference with electrophysiological recordings.
Thus, further testing of the phenotype of the paraventric-hyperpolarizes ARC POMC neurons, an event that is
most likely mediated by the GABAergic NPY/AGRP neu- ular ghrelin-sensitive neurons will be necessary to better
understand ghrelin’s effect in the PVH. Nevertheless, itrons. This is consistent with extensive studies of Dick-
son and others showing that ghrelin or growth hormone appears that in addition to its effects on feeding, one
possible effect of ghrelin is to increase the release ofsecretogogue-induced early-gene expression predomi-
nantly colocalized with NPY/AGRP neurons, rather than NPY onto GABAergic nerve terminals adjacent to CRH
neurons, disinhibiting the CRH neuron and thus stimulat-POMC neurons (Dickson and Luckman, 1997; Hewson
and Dickson, 2000; Wang et al., 2002). ing greater CRH release into the pituitary-hypophyseal
portal circulation, driving increased ACTH secretionThe modest inhibitory effects of ghrelin on POMC
somata may not be sufficient, however, to account for from the pituitary (Arvat et al., 2001).
the potent orexigenic effects of ghrelin (Tschop et al.,
2000, 2002; Nakazato et al., 2001; Wren et al., 2001a; Model of Ghrelin Action in the Brain
The results outlined here provide both anatomical sub-Kamegai et al., 2001; Lu et al., 2001). Thus, we extended
our electrophysiological analysis of ghrelin to a pre- strate and physiological mechanism that can explain
some of the effects of ghrelin on energy homeostasis.viously characterized target site of the AGRP/NPY sys-
tem in food intake regulation, the medial parvocellular This work highlights a new source of ghrelin within the
brain with a unique hypothalamic distribution. Interest-PVH (Cowley et al., 1999; Pronchuk et al., 2002). This
area is a target of hypothalamic ghrelin efferents (see ingly, the internuclear space occupied by ghrelin-immu-
noreactive cells overlaps exactly the hypothalamic pro-above) but is protected by the blood-brain barrier and
thus may be inaccessible to circulating ghrelin (Banks jections from the suprachiasmatic nucleus (Watts et al.,
1987; Horvath, 1997) and the ventral lateral geniculateet al., 2002).
The apparent differential response of PVH CRH versus body of the thalamus (Horvath, 1998). Because the circa-
dian clock resides in the suprachiasmatic nucleus andTRH cells to ghrelin is in line with the reported opposite
effects of ghrelin on the hypothalamo-pituitary-adrenal determines daily rhythms in conjunction with the ventral
Neuron
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however, the same patterns of staining were seen in tissue fromlateral geniculate body, it is reasonable to suggest that
mice. Hypothalami of colchicine-pretreated (intracerebroventricularthe central ghrelin circuit mediates circadian/visual in-
injection 80 g colchicines-HCl in 20 l saline under ketamine anes-formation to its postsynaptic targets, a proposition in
thesia 24 hr prior perfusion) animals were also analyzed for immuno-
line with ghrelin’s meal-initiating effects (Cummings et cytochemical labeling of ghrelin.
al., 2001). The efferents of hypothalamic ghrelin neurons Double labeling immunofluorescence was carried out for ghrelin
(Ghr; rhodamine-conjugated anti-rabbit IgG as secondary antisera)make synaptic contacts appropriate to enable them to
and NPY (mouse anti-NPY; Auspep; fluorescein-conjugated anti-alter the activity of GABAergic NPY-containing nerve
mouse IgG as secondary antisera). Double immunolabeling for Ghrterminals (Figure 7). We show that ghrelin stimulates the
and NPY, Ghr and POMC (rabbit anti--endorphin) (Cowley et al.,activity of NPY/AGRP neurons, primarily through effects
2001), or Ghr and CRH (mouse anti-CRH) used the avidin-biotin
at the neuron terminal. This increased activity is likely peroxidase method, and a dark blue-black nickel-intensified diami-
to enhance the release of neuropeptides and neuro- nobenzidine reaction was used for the labeling of Ghr, while NPY,
POMC, and CRH were labeled using the peroxidase anti-peroxidasetransmitters from NPY/AGRP neurons, modulators that
method and a light brown diaminobenzidine reaction.have been shown to act in an integrated manner to
Visualization of NPY or POMC and GFP was accomplished byincrease food intake and decrease energy expenditure.
fluorescent labeling of either NPY or POMC using primary and sec-Determining how central ghrelin neurons are modulated
ondary (rhodamine-conjugated anti-sheep or anti rabbit IgG) anti-
by central and peripheral signals will be of crucial impor- sera. In some cases to further amplify GFP labeling, GFP was also
tance in understanding the role of this peptide in regulat- visualized using mouse anti-GFP antisera that was visualized by
fluorescein-conjugated anti-mouse IgG, which step then was fol-ing energy homeostasis.
lowed by labeling for NPY or POMC as described above.
Combination of pre- and postembedding immunolabeling ofExperimental Procedures
ghrelin (preembedding immunoperoxidase labeling of large core
vesicles in Figure 2K) and NPY (postembedding labeling of largeAll procedures using vertebrate animals (rats and mice) related to
core vesicles with 25 nm gold-conjugated secondary antisera) wasexperiments of this study have been previously approved by Institu-
used to investigate the ultrastructural relationship between Ghr andtional Animal Care and Use Committees of the participating labora-
NPY (Figure 2K). In accordance with our previously published proto-tories.
col (Cowley et al., 2001; Toran-Allerand et al., 2002), combination
of preembedding immunoperoxidase labeling of TRH and dual post-PCR
embedding labeling of Ghr (large core vesicles labeled with 25 nmFour female rats (Simonsen, Gilroy, CA) were sacrificed after approx-
gold-conjugated anti-rabbit IgG in axon terminals) and GABA (10imately 36 hr of fasting. Hypothalamic, cortex, and stomach RNA
nm gold-conjugated anti-guinea pig IgG over small vesicles in axonwas isolated using TRIzol reagent according to manufacturer’s in-
terminals) was used to analyze the ultrastructural relationship be-struction (Invitrogen, Carlsbad, CA). Reverse transcription (RT) was
tween Ghr, GABA, and TRH (Figure 2L). The steps were as followscarried out on 1 g of total RNA for 2 hr at 37C in a 20 l reaction
(the greatest detail is provided for this triple labeling, because itvolume. PCR was performed in a 50 l volume with 100 ng of hypo-
contains all the methodological steps that were used in all singlethalamic and cortex RNA and 50 ng of stomach RNA (35 cycles of
and multiple labeling experiments). Incubation in rabbit anti-TRH95C for 1 min, 62C for 1 min, and 72C for 1 min). PCR sense and
antisera (1:1000) in PB for 48 hr at 4C. Following several washesantisense primers used were identical to those used by Kojima et
in PB, sections were incubated in the secondary antiserum (biotinyl-al. (1999) (sense primer, 5	-TTG AGC CCA GAG CAC CAG AAA-3	;
ated goat-anti-rabbit IgG, 1:250 in PB, Vector Labs, Burlingame,antisense primer, 5	-AGT TGC AGA GGA GGC AGA AGC T-3	). It
CA) for 2 hr at room temperature, then rinsed in PB for 3 
 10should be noted that approximately four times the material was
min and incubated for 2 hr at room temperature with avidin-biotin-loaded onto the gel for the hypothalamus and cortex compared to
peroxidase, 1:50 in PB (ABC Elite Kit, Vector Labs), followed by athe stomach. The PCR products for the stomach and hypothalamus
diaminobenzidine (DAB) reaction (15 mg DAB, 165 l 0.3% H2O2 inwere sequenced and found to be identical to rat ghrelin.
30 ml PB, 5–10 min at room temperature; diffuse, electro-dense,
cytoplasmic labeling) to visualize the tissue bound peroxidase. After
Immunohistochemistry several rinses in PB, sections were processed for postembedding
Immunolabeling for ghrelin was done using three independently labeling. Sections were dehydrated through increasing ethanol con-
generated affinity-purified polyclonal antisera against ghrelin with centrations (the 70% ethanol containing uranyl acetate; for 30 min)
0% crossreactivity with vasoactive intestinal polypeptide (INCstar, and flat embedded in Durcupan between liquid release (Electron
Stillwater, MA), prolactin releasing peptide (Phoenix Pharmaceuti- Microscopy Sciences, Fort Washington, PA) coated slides and cov-
cals, Belmont, CA), galanin (Peninsula Labs, Belmont, CA), growth erslipped and placed in an oven to polymerize for 48 hr at 60C. Flat
hormone-releasing hormone (Dr. Henryk Urbanski), neuropeptide Y embedded sections were fixed with a drop of embedding medium on
(Auspep Inc, Parkville, Australia), -MSH (Miles Scientific, Naper- the top of cylindrical Durcupan blocks and cured again for 48 hr at
ville, IL), -endorphin (Chemicon, Temecula, CA), MCH (Phoenix 60C. Blocks were then trimmed, and ultrathin sections (60 nm on
Pharmaceuticals), and orexin (Santa Cruz Biotechnology Inc., Santa Reichert-Jung Ultramicrotome) were collected on Formvar-coated
Cruz, CA). These antisera have been shown to detect and recover single slot grids and processed for postembedding labeling of
synthetic ghrelin in ghrelin-spiked plasma samples (data not shown) ghrelin and GABA. These steps were carried out on Millipore-filtered
and to recognize pro-ghrelin in Western blots of homogenates of solutions in humid chambers: (1) 10 min 2% periodic acid; (2) rinse
the hypothalamus, stomach, and spleen (Figure 1B). Less intense in double distilled water (DDW); (3) 10 min 2% sodium metaperiodate
signals in homogenates of the hypothalamus indicated lower pro- in DDW; (3) wash in DDW; (4) 3 
 2 min rinse in pH 7.4 Tris-buffered
ghrelin expression levels in comparison to other ghrelin-expressing saline containing 0.1% Triton X-100 (TBST); (5) 10 min in TBST
tissues. containing 0.1% sodium borohydride and 50 mM glycine; (6) 10 min
Western blot analyses were also carried out with these antisera in TBST  2% BSA; (7) incubation for 1–2 hr in rabbit anti-ghrelin
on intact rat hypothalamic and stomach homogenates. The antisera diluted 1:1000 in TBST  2% BSA; (8) 2 
 10 min wash in TBST;
allowed the visualization of a band at 13 kDa, corresponding to the 10 min rinse in TBST 2% BSA; (9) 2 hr incubation in gold-conjugated
estimated size of pro-ghrelin. Immunolabeling with these antisera (25 nm) anti-rabbit IgG diluted 1:20 in the same buffer; (10) 3 
 3 min
in 1:200–1:2000 dilutions using the avidin-biotin-peroxidase method wash in DDW. Sections were then further immunostained for GABA.
and diaminobenzidine as chromogen resulted in specific labeling The same steps were taken as for the ghrelin immunolabeling, ex-
in hypothalamic sites that was abolished by preadsorption of the cept that antisera against GABA was used (guinea-pig anti-GABA;
antisera with ghrelin. Furthermore, all the antisera displayed identi- 1:1000) and the secondary antisera was 10 nm gold-conjugated
cal patterns of immunolabeling of rat hypothalamus. Data reported anti-guinea pig IgG. Sections were then contrasted with saturated
uranyl acetate (10 min) and lead citrate (20–30 s). Ultrathin sectionsare from paraformaldehyde (4%) or acrolein (2%)-fixed rat tissue;
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were examined using a Philips CM-10 electron microscope. An axon Electrophysiology
The effect of ghrelin on NPY neurons was determined using electro-terminal was considered to contain ghrelin (or GABA) if (1) the num-
ber of gold particles overlaying synaptic vesicles in a 0.5 m2 region physiological recordings from identified NPY neurons, in hypothala-
mic slices from NPY-Sapphire Green Fluorescent Protein mice (NPY-of the bouton was at least three times higher than the number of
gold particles in any given 0.5 m2 region in other compartments SFP mice). These mice express a transgene containing Sapphire
GFP under the control of 150 kb of Npy gene regulatory elements.of the cells (these areas include regions of the cytosol in neuronal
and astrocytic cell bodies and processes), and (2) the criteria of (1) This transgene is the same as that used to drive the eutopic expres-
sion of CRE in NPY neurons (DeFalco et al., 2001), except that SFPcould be applied to the same bouton in immediate preceding and
subsequent serial sections. has been substituted for CRE. A detailed characterization of these
mice has been completed and the expression of SFP is limited to
NPY neurons (unpublished). Electrophysiological recordings were
Ghrelin Knockout Mice made from mouse arcuate NPY neurons as previously described for
To further assess specificity of the ghrelin antisera, we have ana- POMC neurons (Cowley et al., 2001; Heisler et al., 2002; Batterham et
lyzed the stomach and hypothalami of ghrelin knockout mice. De- al., 2002).
tailed description of these animals and their phenotypes is the sub- Recording were made from POMC and non-POMC neurons in 180
ject of another submission. In short, mouse ghrelin genomic DNA m hypothalamic slices as previously described (Cowley et al., 2001;
clones were isolated from Lambda KOS genomic library using exon- Heisler et al., 2002; Batterham et al., 2002). In preliminary experi-
4- and exon-5-specific primers. The IRES-LacZ/MC1-Neo selection ments, we filled some neurons with neurobiotin and performed post-
cassette was inserted into the ghrelin locus as a SfiI fragment by recording immunohistochemistry to confirm that the electrophysio-
yeast-mediated recombination to replace ghrelin exons 2 and 3 that logical recording was made from a fluorescent neuron. In latter
encode ghrelin. The targeting vector consists of 3.0 kb and 4.5 kb experiments, we followed the diffusion, and thus loss of fluores-
homologous regions of genomic DNA at 5	 and 3	 of the IRES- cence, of GFP or SFP from the cell into the patch electrode. Electro-
lacZ/MC1-Neo cassette, respectively. The targeted ES cells and physiological recordings were made from medial parvocellular PVH
subsequently agouti pups, heterozygotes, and homozygotes were neurons in hypothalamic slices from rats as previously described
genotyped by Southern analysis using a 5	-probe, a 3	-probe, and (Cowley et al., 1999; Pronchuk et al., 2002). Slow (4 s) voltage
exon probe. ramps from 110 to 40 mV were applied to all PVH neurons in
Immunolabeling for ghrelin on 40 m thick sections of the hypo- control, and as appropriate, to assess possible postsynaptic conse-
thalamus and stomach of knockout and wild-type animals were quences of all experimental manipulations. Some recordings here
carried out as described above. Knockout and wild-type sections were made using perforated patch rather than conventional whole-
from one knockout and one wild-type animal were processed in the cell techniques; whole-cell configuration was reached within 10 min
same vial. Three runs of such paired sections were analyzed, thus of seal formation, with 9–10 MOhm access resistance. The electrode
totaling three knockout and three wild-type mice. solution for perforated patch recordings contained (in mM) K Gluco-
nate, 125; MgCl2, 5; HEPES, 10; EGTA, 10; Nystatin, 1.5%; biocytin,
1.5%). At the end of perforated patch recording experiments, bio-
Ghrelin Binding cytin in the pipette solution was electroporated through the patch
Tissues were fixed overnight in zinc-buffered formalin and then by depolarizing voltage clamp pulses (60 mV, 100 ms, 5 Hz) applied
transferred to 70% ethanol prior to processing through paraffin. Five for 5–6 min while the cell was held at 60 mV, to post hoc identify
micron sections were prepared and placed on positive charged the PVH neurons. The slice was then fixed overnight in a 4% para-
slides. The slides were then baked overnight at 60C in an oven formaldehyde-sodium phosphate-buffered saline (PBS, pH 7.4) fixa-
and then deparaffinized in xylene and rehydrated through graded tive at 4C, then washed three times for 10 min in 0.02 M potassium
alcohols to water. Antigen retrieval was performed by immersing PBS (KPBS) and dehydrated at 4C in 20% sucrose overnight. Thin
the slides in Target Retrieval Solution (Dako Corp., Carpinteria, CA) (20 m) sections were cut with a cryostat (Leica, Jung Frigocut
for 20 min at 90C (in a water bath), cooling at room temperature 2800E), collected into 0.02 M KPBS, and washed three times for 10
for 10 min, washing in water, and then proceeding with immunostain- min in KPBS. Sections were then incubated for 72 hr at 4C in a
ing. All subsequent staining steps were performed on the Dako mixture of anti-CRF (1:3000, guinea pig, Peninsula Laboratories)
Autoimmunostainer; incubations were done at room temperature, and anti-TRH (1:3000, rabbit, Dr. Eduardo Nillni, Brown University),
and Tris-buffered saline plus 0.05% Tween 20 (pH 7.4) (TBS, Dako diluted in 0.02 M KPBS with 0.3% Triton X-100 (Sigma) and 2%
Corp.) was used for all washes and diluents. Thorough washing was normal goat serum (Rockland). Sections were then washed five
performed after each incubation. Slides were blocked with protein times for 10 min and then incubated for 50–60 min in a mixture of
blocking solution (Dako) for 25 min; after washing, 10 g/ml of secondary antibodies comprising anti-rabbit ALEXA 568 (1:200),
biotinylated ghrelin (Eli Lilly and Co., Inc., Indianapolis, IN) was then anti-guinea pig ALEXA 488 (1:200), and streptavidin-conjugated
added to the slides and incubated for 60 min. A streptavidin-horse- ALEXA 350 (1:200, to reveal biocytin labeling) (all from Molecular
radish peroxidase kit (Dako LSAB2) was then utilized along with Probes, Eugene, OR), diluted in 0.02 M KPBS with 0.3% Triton X-100
Alexa 568 dye (red fluorescence) to detect the bound avidin-biotin- and 2% normal goat serum. Sections were mounted in Prolong anti-
ghrelin complexes. The slides were briefly counterstained with he- fading medium (Molecular Probes), and images were taken and
matoxylin, removed from the autostainer, and dehydrated through processed using a Zeiss LSM510 confocal microscope. Data were
graded alcohols to xylene. The slides were coverslipped with a analyzed by ANOVA or Wilcoxon’s Signed Rank Test (for nonpara-
permanent mounting medium and analyzed with a fluorescence mi- metric data) using Prism (GraphPad Software, San Diego, CA).
croscope. Some of the biotinylated ghrelin-labled slides were further
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